Home > > > > > Report Detail

Global Calcium Channel Blocker Market Insights, Forecast to 2026

Publisher Name :
Date: 05-May-2020
No. of pages: 111
Inquire Before Buying

Calcium channel blockers(CCBs) are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way.

The demand of Calcium Channel Blocker is concentrated in developed areas like USA and Europe. In 2016, the consumption of Calcium Channel Blocker in USA was 26.78%, ahead of other regions. Other regions also enjoy the major market share in global region.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Calcium Channel Blocker 3900 market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Calcium Channel Blocker 3900 industry.

Based on our recent survey, we have several different scenarios about the Calcium Channel Blocker 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 74 million in 2019. The market size of Calcium Channel Blocker 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Calcium Channel Blocker market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Calcium Channel Blocker market in terms of both revenue and volume.

Players, stakeholders, and other participants in the global Calcium Channel Blocker market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Sales and Pricing Analyses

Readers are provided with deeper sales analysis and pricing analysis for the global Calcium Channel Blocker market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.

In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Calcium Channel Blocker market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Calcium Channel Blocker market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Calcium Channel Blocker market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Calcium Channel Blocker market.

The following manufacturers are covered in this report:

- Pfizer

- Aventis

- Searle

- Bayer

- AstraZeneca

- Knoll Pharmaceuticals

- Wyeth-Ayerst

- AstraZeneca

- Novartis

- Sanofi

Calcium Channel Blocker Breakdown Data by Type

- Dihydropyridine

- Diltiazem

- Verapamil

- Others

Calcium Channel Blocker Breakdown Data by Application

- Hypertension

- Coronary Artery Disease

- Arrhythmia

- Cardiomyopathy

Global Calcium Channel Blocker Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Calcium Channel Blocker Product Introduction
1.2 Market Segments
1.3 Key Calcium Channel Blocker Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Calcium Channel Blocker Market Size Growth Rate by Type
1.4.2 Dihydropyridine
1.4.3 Diltiazem
1.4.4 Verapamil
1.4.5 Others
1.5 Market by Application
1.5.1 Global Calcium Channel Blocker Market Size Growth Rate by Application
1.5.2 Hypertension
1.5.3 Coronary Artery Disease
1.5.4 Arrhythmia
1.5.5 Cardiomyopathy
1.6 Coronavirus Disease 2019 (Covid-19): Calcium Channel Blocker Industry Impact
1.6.1 How the Covid-19 is Affecting the Calcium Channel Blocker Industry
1.6.1.1 Calcium Channel Blocker Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Calcium Channel Blocker Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Calcium Channel Blocker Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Calcium Channel Blocker Market Size Estimates and Forecasts
2.1.1 Global Calcium Channel Blocker Revenue 2015-2026
2.1.2 Global Calcium Channel Blocker Sales 2015-2026
2.2 Calcium Channel Blocker Market Size by Region: 2020 Versus 2026
2.2.1 Global Calcium Channel Blocker Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Calcium Channel Blocker Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Calcium Channel Blocker Competitor Landscape by Players
3.1 Calcium Channel Blocker Sales by Manufacturers
3.1.1 Calcium Channel Blocker Sales by Manufacturers (2015-2020)
3.1.2 Calcium Channel Blocker Sales Market Share by Manufacturers (2015-2020)
3.2 Calcium Channel Blocker Revenue by Manufacturers
3.2.1 Calcium Channel Blocker Revenue by Manufacturers (2015-2020)
3.2.2 Calcium Channel Blocker Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Calcium Channel Blocker Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Calcium Channel Blocker Revenue in 2019
3.2.5 Global Calcium Channel Blocker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Calcium Channel Blocker Price by Manufacturers
3.4 Calcium Channel Blocker Manufacturing Base Distribution, Product Types
3.4.1 Calcium Channel Blocker Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Calcium Channel Blocker Product Type
3.4.3 Date of International Manufacturers Enter into Calcium Channel Blocker Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Calcium Channel Blocker Market Size by Type (2015-2020)
4.1.1 Global Calcium Channel Blocker Sales by Type (2015-2020)
4.1.2 Global Calcium Channel Blocker Revenue by Type (2015-2020)
4.1.3 Calcium Channel Blocker Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Calcium Channel Blocker Market Size Forecast by Type (2021-2026)
4.2.1 Global Calcium Channel Blocker Sales Forecast by Type (2021-2026)
4.2.2 Global Calcium Channel Blocker Revenue Forecast by Type (2021-2026)
4.2.3 Calcium Channel Blocker Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Calcium Channel Blocker Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Calcium Channel Blocker Market Size by Application (2015-2020)
5.1.1 Global Calcium Channel Blocker Sales by Application (2015-2020)
5.1.2 Global Calcium Channel Blocker Revenue by Application (2015-2020)
5.1.3 Calcium Channel Blocker Price by Application (2015-2020)
5.2 Calcium Channel Blocker Market Size Forecast by Application (2021-2026)
5.2.1 Global Calcium Channel Blocker Sales Forecast by Application (2021-2026)
5.2.2 Global Calcium Channel Blocker Revenue Forecast by Application (2021-2026)
5.2.3 Global Calcium Channel Blocker Price Forecast by Application (2021-2026)
6 North America
6.1 North America Calcium Channel Blocker by Country
6.1.1 North America Calcium Channel Blocker Sales by Country
6.1.2 North America Calcium Channel Blocker Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Calcium Channel Blocker Market Facts & Figures by Type
6.3 North America Calcium Channel Blocker Market Facts & Figures by Application
7 Europe
7.1 Europe Calcium Channel Blocker by Country
7.1.1 Europe Calcium Channel Blocker Sales by Country
7.1.2 Europe Calcium Channel Blocker Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Calcium Channel Blocker Market Facts & Figures by Type
7.3 Europe Calcium Channel Blocker Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Calcium Channel Blocker by Region
8.1.1 Asia Pacific Calcium Channel Blocker Sales by Region
8.1.2 Asia Pacific Calcium Channel Blocker Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Calcium Channel Blocker Market Facts & Figures by Type
8.3 Asia Pacific Calcium Channel Blocker Market Facts & Figures by Application
9 Latin America
9.1 Latin America Calcium Channel Blocker by Country
9.1.1 Latin America Calcium Channel Blocker Sales by Country
9.1.2 Latin America Calcium Channel Blocker Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Calcium Channel Blocker Market Facts & Figures by Type
9.3 Central & South America Calcium Channel Blocker Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Calcium Channel Blocker by Country
10.1.1 Middle East and Africa Calcium Channel Blocker Sales by Country
10.1.2 Middle East and Africa Calcium Channel Blocker Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Calcium Channel Blocker Market Facts & Figures by Type
10.3 Middle East and Africa Calcium Channel Blocker Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description, Business Overview and Total Revenue
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Calcium Channel Blocker Products Offered
11.1.5 Pfizer Recent Development
11.2 Aventis
11.2.1 Aventis Corporation Information
11.2.2 Aventis Description, Business Overview and Total Revenue
11.2.3 Aventis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Aventis Calcium Channel Blocker Products Offered
11.2.5 Aventis Recent Development
11.3 Searle
11.3.1 Searle Corporation Information
11.3.2 Searle Description, Business Overview and Total Revenue
11.3.3 Searle Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Searle Calcium Channel Blocker Products Offered
11.3.5 Searle Recent Development
11.4 Bayer
11.4.1 Bayer Corporation Information
11.4.2 Bayer Description, Business Overview and Total Revenue
11.4.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Bayer Calcium Channel Blocker Products Offered
11.4.5 Bayer Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Description, Business Overview and Total Revenue
11.5.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.5.4 AstraZeneca Calcium Channel Blocker Products Offered
11.5.5 AstraZeneca Recent Development
11.6 Knoll Pharmaceuticals
11.6.1 Knoll Pharmaceuticals Corporation Information
11.6.2 Knoll Pharmaceuticals Description, Business Overview and Total Revenue
11.6.3 Knoll Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Knoll Pharmaceuticals Calcium Channel Blocker Products Offered
11.6.5 Knoll Pharmaceuticals Recent Development
11.7 Wyeth-Ayerst
11.7.1 Wyeth-Ayerst Corporation Information
11.7.2 Wyeth-Ayerst Description, Business Overview and Total Revenue
11.7.3 Wyeth-Ayerst Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Wyeth-Ayerst Calcium Channel Blocker Products Offered
11.7.5 Wyeth-Ayerst Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Corporation Information
11.8.2 AstraZeneca Description, Business Overview and Total Revenue
11.8.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.8.4 AstraZeneca Calcium Channel Blocker Products Offered
11.8.5 AstraZeneca Recent Development
11.9 Novartis
11.9.1 Novartis Corporation Information
11.9.2 Novartis Description, Business Overview and Total Revenue
11.9.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Novartis Calcium Channel Blocker Products Offered
11.9.5 Novartis Recent Development
11.10 Sanofi
11.10.1 Sanofi Corporation Information
11.10.2 Sanofi Description, Business Overview and Total Revenue
11.10.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Sanofi Calcium Channel Blocker Products Offered
11.10.5 Sanofi Recent Development
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description, Business Overview and Total Revenue
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Calcium Channel Blocker Products Offered
11.1.5 Pfizer Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Calcium Channel Blocker Market Estimates and Projections by Region
12.1.1 Global Calcium Channel Blocker Sales Forecast by Regions 2021-2026
12.1.2 Global Calcium Channel Blocker Revenue Forecast by Regions 2021-2026
12.2 North America Calcium Channel Blocker Market Size Forecast (2021-2026)
12.2.1 North America: Calcium Channel Blocker Sales Forecast (2021-2026)
12.2.2 North America: Calcium Channel Blocker Revenue Forecast (2021-2026)
12.2.3 North America: Calcium Channel Blocker Market Size Forecast by Country (2021-2026)
12.3 Europe Calcium Channel Blocker Market Size Forecast (2021-2026)
12.3.1 Europe: Calcium Channel Blocker Sales Forecast (2021-2026)
12.3.2 Europe: Calcium Channel Blocker Revenue Forecast (2021-2026)
12.3.3 Europe: Calcium Channel Blocker Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Calcium Channel Blocker Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Calcium Channel Blocker Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Calcium Channel Blocker Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Calcium Channel Blocker Market Size Forecast by Region (2021-2026)
12.5 Latin America Calcium Channel Blocker Market Size Forecast (2021-2026)
12.5.1 Latin America: Calcium Channel Blocker Sales Forecast (2021-2026)
12.5.2 Latin America: Calcium Channel Blocker Revenue Forecast (2021-2026)
12.5.3 Latin America: Calcium Channel Blocker Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Calcium Channel Blocker Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Calcium Channel Blocker Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Calcium Channel Blocker Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Calcium Channel Blocker Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Calcium Channel Blocker Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Calcium Channel Blocker Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Calcium Channel Blocker Market Segments
Table 2. Ranking of Global Top Calcium Channel Blocker Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Calcium Channel Blocker Market Size Growth Rate by Type 2020-2026 (Kg) & (US$ Million)
Table 4. Major Manufacturers of Dihydropyridine
Table 5. Major Manufacturers of Diltiazem
Table 6. Major Manufacturers of Verapamil
Table 7. Major Manufacturers of Others
Table 8. COVID-19 Impact Global Market: (Four Calcium Channel Blocker Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Calcium Channel Blocker Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Calcium Channel Blocker Players to Combat Covid-19 Impact
Table 13. Global Calcium Channel Blocker Market Size Growth Rate by Application 2020-2026 (Kg)
Table 14. Global Calcium Channel Blocker Market Size by Region (Kg) & (US$ Million): 2020 VS 2026
Table 15. Global Calcium Channel Blocker Sales by Regions 2015-2020 (Kg)
Table 16. Global Calcium Channel Blocker Sales Market Share by Regions (2015-2020)
Table 17. Global Calcium Channel Blocker Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Calcium Channel Blocker Sales by Manufacturers (2015-2020) (Kg)
Table 19. Global Calcium Channel Blocker Sales Share by Manufacturers (2015-2020)
Table 20. Global Calcium Channel Blocker Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Calcium Channel Blocker by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Calcium Channel Blocker as of 2019)
Table 22. Calcium Channel Blocker Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Calcium Channel Blocker Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Calcium Channel Blocker Price (2015-2020) (USD/g)
Table 25. Calcium Channel Blocker Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Calcium Channel Blocker Product Type
Table 27. Date of International Manufacturers Enter into Calcium Channel Blocker Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Calcium Channel Blocker Sales by Type (2015-2020) (Kg)
Table 30. Global Calcium Channel Blocker Sales Share by Type (2015-2020)
Table 31. Global Calcium Channel Blocker Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Calcium Channel Blocker Revenue Share by Type (2015-2020)
Table 33. Calcium Channel Blocker Average Selling Price (ASP) by Type 2015-2020 (USD/g)
Table 34. Global Calcium Channel Blocker Sales by Application (2015-2020) (Kg)
Table 35. Global Calcium Channel Blocker Sales Share by Application (2015-2020)
Table 36. North America Calcium Channel Blocker Sales by Country (2015-2020) (Kg)
Table 37. North America Calcium Channel Blocker Sales Market Share by Country (2015-2020)
Table 38. North America Calcium Channel Blocker Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Calcium Channel Blocker Revenue Market Share by Country (2015-2020)
Table 40. North America Calcium Channel Blocker Sales by Type (2015-2020) (Kg)
Table 41. North America Calcium Channel Blocker Sales Market Share by Type (2015-2020)
Table 42. North America Calcium Channel Blocker Sales by Application (2015-2020) (Kg)
Table 43. North America Calcium Channel Blocker Sales Market Share by Application (2015-2020)
Table 44. Europe Calcium Channel Blocker Sales by Country (2015-2020) (Kg)
Table 45. Europe Calcium Channel Blocker Sales Market Share by Country (2015-2020)
Table 46. Europe Calcium Channel Blocker Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Calcium Channel Blocker Revenue Market Share by Country (2015-2020)
Table 48. Europe Calcium Channel Blocker Sales by Type (2015-2020) (Kg)
Table 49. Europe Calcium Channel Blocker Sales Market Share by Type (2015-2020)
Table 50. Europe Calcium Channel Blocker Sales by Application (2015-2020) (Kg)
Table 51. Europe Calcium Channel Blocker Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Calcium Channel Blocker Sales by Region (2015-2020) (Kg)
Table 53. Asia Pacific Calcium Channel Blocker Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Calcium Channel Blocker Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Calcium Channel Blocker Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Calcium Channel Blocker Sales by Type (2015-2020) (Kg)
Table 57. Asia Pacific Calcium Channel Blocker Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Calcium Channel Blocker Sales by Application (2015-2020) (Kg)
Table 59. Asia Pacific Calcium Channel Blocker Sales Market Share by Application (2015-2020)
Table 60. Latin America Calcium Channel Blocker Sales by Country (2015-2020) (Kg)
Table 61. Latin America Calcium Channel Blocker Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Calcium Channel Blocker Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Calcium Channel Blocker Revenue Market Share by Country (2015-2020)
Table 64. Latin America Calcium Channel Blocker Sales by Type (2015-2020) (Kg)
Table 65. Latin America Calcium Channel Blocker Sales Market Share by Type (2015-2020)
Table 66. Latin America Calcium Channel Blocker Sales by Application (2015-2020) (Kg)
Table 67. Latin America Calcium Channel Blocker Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Calcium Channel Blocker Sales by Country (2015-2020) (Kg)
Table 69. Middle East and Africa Calcium Channel Blocker Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Calcium Channel Blocker Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Calcium Channel Blocker Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Calcium Channel Blocker Sales by Type (2015-2020) (Kg)
Table 73. Middle East and Africa Calcium Channel Blocker Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Calcium Channel Blocker Sales by Application (2015-2020) (Kg)
Table 75. Middle East and Africa Calcium Channel Blocker Sales Market Share by Application (2015-2020)
Table 76. Pfizer Corporation Information
Table 77. Pfizer Description and Major Businesses
Table 78. Pfizer Calcium Channel Blocker Production (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 79. Pfizer Product
Table 80. Pfizer Recent Development
Table 81. Aventis Corporation Information
Table 82. Aventis Description and Major Businesses
Table 83. Aventis Calcium Channel Blocker Production (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 84. Aventis Product
Table 85. Aventis Recent Development
Table 86. Searle Corporation Information
Table 87. Searle Description and Major Businesses
Table 88. Searle Calcium Channel Blocker Production (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 89. Searle Product
Table 90. Searle Recent Development
Table 91. Bayer Corporation Information
Table 92. Bayer Description and Major Businesses
Table 93. Bayer Calcium Channel Blocker Production (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 94. Bayer Product
Table 95. Bayer Recent Development
Table 96. AstraZeneca Corporation Information
Table 97. AstraZeneca Description and Major Businesses
Table 98. AstraZeneca Calcium Channel Blocker Production (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 99. AstraZeneca Product
Table 100. AstraZeneca Recent Development
Table 101. Knoll Pharmaceuticals Corporation Information
Table 102. Knoll Pharmaceuticals Description and Major Businesses
Table 103. Knoll Pharmaceuticals Calcium Channel Blocker Production (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 104. Knoll Pharmaceuticals Product
Table 105. Knoll Pharmaceuticals Recent Development
Table 106. Wyeth-Ayerst Corporation Information
Table 107. Wyeth-Ayerst Description and Major Businesses
Table 108. Wyeth-Ayerst Calcium Channel Blocker Production (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 109. Wyeth-Ayerst Product
Table 110. Wyeth-Ayerst Recent Development
Table 111. AstraZeneca Corporation Information
Table 112. AstraZeneca Description and Major Businesses
Table 113. AstraZeneca Calcium Channel Blocker Production (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 114. AstraZeneca Product
Table 115. AstraZeneca Recent Development
Table 116. Novartis Corporation Information
Table 117. Novartis Description and Major Businesses
Table 118. Novartis Calcium Channel Blocker Production (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 119. Novartis Product
Table 120. Novartis Recent Development
Table 121. Sanofi Corporation Information
Table 122. Sanofi Description and Major Businesses
Table 123. Sanofi Calcium Channel Blocker Production (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 124. Sanofi Product
Table 125. Sanofi Recent Development
Table 126. Global Calcium Channel Blocker Sales Forecast by Regions (2021-2026) (Kg)
Table 127. Global Calcium Channel Blocker Sales Market Share Forecast by Regions (2021-2026)
Table 128. Global Calcium Channel Blocker Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 129. Global Calcium Channel Blocker Revenue Market Share Forecast by Regions (2021-2026)
Table 130. North America: Calcium Channel Blocker Sales Forecast by Country (2021-2026) (Kg)
Table 131. North America: Calcium Channel Blocker Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Europe: Calcium Channel Blocker Sales Forecast by Country (2021-2026) (Kg)
Table 133. Europe: Calcium Channel Blocker Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Asia Pacific: Calcium Channel Blocker Sales Forecast by Region (2021-2026) (Kg)
Table 135. Asia Pacific: Calcium Channel Blocker Revenue Forecast by Region (2021-2026) (US$ Million)
Table 136. Latin America: Calcium Channel Blocker Sales Forecast by Country (2021-2026) (Kg)
Table 137. Latin America: Calcium Channel Blocker Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Middle East and Africa: Calcium Channel Blocker Sales Forecast by Country (2021-2026) (Kg)
Table 139. Middle East and Africa: Calcium Channel Blocker Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 141. Key Challenges
Table 142. Market Risks
Table 143. Main Points Interviewed from Key Calcium Channel Blocker Players
Table 144. Calcium Channel Blocker Customers List
Table 145. Calcium Channel Blocker Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Calcium Channel Blocker Product Picture
Figure 2. Global Calcium Channel Blocker Sales Market Share by Type in 2020 & 2026
Figure 3. Dihydropyridine Product Picture
Figure 4. Diltiazem Product Picture
Figure 5. Verapamil Product Picture
Figure 6. Others Product Picture
Figure 7. Global Calcium Channel Blocker Sales Market Share by Application in 2020 & 2026
Figure 8. Hypertension
Figure 9. Coronary Artery Disease
Figure 10. Arrhythmia
Figure 11. Cardiomyopathy
Figure 12. Calcium Channel Blocker Report Years Considered
Figure 13. Global Calcium Channel Blocker Market Size 2015-2026 (US$ Million)
Figure 14. Global Calcium Channel Blocker Sales 2015-2026 (Kg)
Figure 15. Global Calcium Channel Blocker Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Calcium Channel Blocker Sales Market Share by Region (2015-2020)
Figure 17. Global Calcium Channel Blocker Sales Market Share by Region in 2019
Figure 18. Global Calcium Channel Blocker Revenue Market Share by Region (2015-2020)
Figure 19. Global Calcium Channel Blocker Revenue Market Share by Region in 2019
Figure 20. Global Calcium Channel Blocker Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Calcium Channel Blocker Revenue in 2019
Figure 22. Calcium Channel Blocker Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Calcium Channel Blocker Sales Market Share by Type (2015-2020)
Figure 24. Global Calcium Channel Blocker Sales Market Share by Type in 2019
Figure 25. Global Calcium Channel Blocker Revenue Market Share by Type (2015-2020)
Figure 26. Global Calcium Channel Blocker Revenue Market Share by Type in 2019
Figure 27. Global Calcium Channel Blocker Market Share by Price Range (2015-2020)
Figure 28. Global Calcium Channel Blocker Sales Market Share by Application (2015-2020)
Figure 29. Global Calcium Channel Blocker Sales Market Share by Application in 2019
Figure 30. Global Calcium Channel Blocker Revenue Market Share by Application (2015-2020)
Figure 31. Global Calcium Channel Blocker Revenue Market Share by Application in 2019
Figure 32. North America Calcium Channel Blocker Sales Growth Rate 2015-2020 (Kg)
Figure 33. North America Calcium Channel Blocker Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Calcium Channel Blocker Sales Market Share by Country in 2019
Figure 35. North America Calcium Channel Blocker Revenue Market Share by Country in 2019
Figure 36. U.S. Calcium Channel Blocker Sales Growth Rate (2015-2020) (Kg)
Figure 37. U.S. Calcium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Calcium Channel Blocker Sales Growth Rate (2015-2020) (Kg)
Figure 39. Canada Calcium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Calcium Channel Blocker Market Share by Type in 2019
Figure 41. North America Calcium Channel Blocker Market Share by Application in 2019
Figure 42. Europe Calcium Channel Blocker Sales Growth Rate 2015-2020 (Kg)
Figure 43. Europe Calcium Channel Blocker Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Calcium Channel Blocker Sales Market Share by Country in 2019
Figure 45. Europe Calcium Channel Blocker Revenue Market Share by Country in 2019
Figure 46. Germany Calcium Channel Blocker Sales Growth Rate (2015-2020) (Kg)
Figure 47. Germany Calcium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Calcium Channel Blocker Sales Growth Rate (2015-2020) (Kg)
Figure 49. France Calcium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Calcium Channel Blocker Sales Growth Rate (2015-2020) (Kg)
Figure 51. U.K. Calcium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Calcium Channel Blocker Sales Growth Rate (2015-2020) (Kg)
Figure 53. Italy Calcium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Calcium Channel Blocker Sales Growth Rate (2015-2020) (Kg)
Figure 55. Russia Calcium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Calcium Channel Blocker Market Share by Type in 2019
Figure 57. Europe Calcium Channel Blocker Market Share by Application in 2019
Figure 58. Asia Pacific Calcium Channel Blocker Sales Growth Rate 2015-2020 (Kg)
Figure 59. Asia Pacific Calcium Channel Blocker Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Calcium Channel Blocker Sales Market Share by Region in 2019
Figure 61. Asia Pacific Calcium Channel Blocker Revenue Market Share by Region in 2019
Figure 62. China Calcium Channel Blocker Sales Growth Rate (2015-2020) (Kg)
Figure 63. China Calcium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Calcium Channel Blocker Sales Growth Rate (2015-2020) (Kg)
Figure 65. Japan Calcium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Calcium Channel Blocker Sales Growth Rate (2015-2020) (Kg)
Figure 67. South Korea Calcium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Calcium Channel Blocker Sales Growth Rate (2015-2020) (Kg)
Figure 69. India Calcium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Calcium Channel Blocker Sales Growth Rate (2015-2020) (Kg)
Figure 71. Australia Calcium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Calcium Channel Blocker Sales Growth Rate (2015-2020) (Kg)
Figure 73. Taiwan Calcium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Calcium Channel Blocker Sales Growth Rate (2015-2020) (Kg)
Figure 75. Indonesia Calcium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Calcium Channel Blocker Sales Growth Rate (2015-2020) (Kg)
Figure 77. Thailand Calcium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Calcium Channel Blocker Sales Growth Rate (2015-2020) (Kg)
Figure 79. Malaysia Calcium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Calcium Channel Blocker Sales Growth Rate (2015-2020) (Kg)
Figure 81. Philippines Calcium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Calcium Channel Blocker Sales Growth Rate (2015-2020) (Kg)
Figure 83. Vietnam Calcium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Calcium Channel Blocker Market Share by Type in 2019
Figure 85. Asia Pacific Calcium Channel Blocker Market Share by Application in 2019
Figure 86. Latin America Calcium Channel Blocker Sales Growth Rate 2015-2020 (Kg)
Figure 87. Latin America Calcium Channel Blocker Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Calcium Channel Blocker Sales Market Share by Country in 2019
Figure 89. Latin America Calcium Channel Blocker Revenue Market Share by Country in 2019
Figure 90. Mexico Calcium Channel Blocker Sales Growth Rate (2015-2020) (Kg)
Figure 91. Mexico Calcium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Calcium Channel Blocker Sales Growth Rate (2015-2020) (Kg)
Figure 93. Brazil Calcium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Calcium Channel Blocker Sales Growth Rate (2015-2020) (Kg)
Figure 95. Argentina Calcium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Calcium Channel Blocker Market Share by Type in 2019
Figure 97. Latin America Calcium Channel Blocker Market Share by Application in 2019
Figure 98. Middle East and Africa Calcium Channel Blocker Sales Growth Rate 2015-2020 (Kg)
Figure 99. Middle East and Africa Calcium Channel Blocker Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Calcium Channel Blocker Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Calcium Channel Blocker Revenue Market Share by Country in 2019
Figure 102. Turkey Calcium Channel Blocker Sales Growth Rate (2015-2020) (Kg)
Figure 103. Turkey Calcium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Calcium Channel Blocker Sales Growth Rate (2015-2020) (Kg)
Figure 105. Saudi Arabia Calcium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. UAE Calcium Channel Blocker Sales Growth Rate (2015-2020) (Kg)
Figure 107. UAE Calcium Channel Blocker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Calcium Channel Blocker Market Share by Type in 2019
Figure 109. Middle East and Africa Calcium Channel Blocker Market Share by Application in 2019
Figure 110. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Searle Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Knoll Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Wyeth-Ayerst Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Novartis Total Revenue (US$ Million): 2019 Co
  • Global Pulmonary Arterial Hypertension (Pah) Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Pulmonary Arterial Hypertension (Pah) Medicine market: According to our latest research, the global Pulmonary Arterial Hypertension (Pah) Medicine market looks promising in the next 5 years. As of 2022, the global Pulmonary Arterial Hypertension (Pah) Medicine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to ......
  • Global Nifedipine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Nifedipine market: According to our latest research, the global Nifedipine market looks promising in the next 5 years. As of 2022, the global Nifedipine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nifedipine market, with a systematical de......
  • Global Amlodipine Besylate Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 115
    The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......
  • Pulmonary Arterial Hypertension (PAH) Drugs - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 112
    The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Arterial Hypertension (PAH) Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Pulmonary Arterial Hypertension (PAH) Drugs market. Inhalation, one of the segments analysed in this report, is projected to record % ......
  • Captopril API - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 100
    The global Captopril API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Captopril API in various end use industries. The expanding demands from the Captopril Tablet, Compound Captopril Tablet and Captopril Injection,, are propelling Captopril API market. 98% Captopril API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......
  • Telmisartan - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 107
    The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried......
  • Global Ambrisentan Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 106
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Ambrisentan Market Research Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 132
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Amlodipine Besylate Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 133
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs